Ethambutol Genus Pharmaceuticals

Ethambutol Hydrochloride is an antibiotic medication used to treat tuberculosis. It works by stopping the growth of bacteria. Ethambutol Hydrochloride is manufactured by Genus Pharmaceuticals Holdings Limited.

Ethambutol Hydrochloride is primarily used in the treatment of tuberculosis, a bacterial infection that mainly affects the lungs. It is often used in combination with other antibiotics to effectively manage the condition. Ethambutol Hydrochloride is designed for oral use and is part of a comprehensive treatment plan for tuberculosis.

Common effects of Ethambutol Hydrochloride may include changes in vision, such as blurred vision or difficulty distinguishing colors. Some individuals may also experience nausea, vomiting, or loss of appetite. These effects can vary from person to person and are not experienced by everyone who takes the medication.

Ethambutol Hydrochloride should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should avoid alcohol while taking this medication, as it may increase the risk of side effects. Regular eye exams are recommended for those using Ethambutol Hydrochloride to monitor for any vision changes.

Ethambutol Hydrochloride may interact with certain medications, including other antibiotics and medications that affect the liver. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided while taking Ethambutol Hydrochloride, as it can increase the risk of side effects.